Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Blood-Brain Barrier: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Blood-Brain Barrier is a biological pathway involved in neurodegeneration research. Key relationships include: activates, therapeutic target, associated with. Associated with ALS, Aging, Als. Connected to 990 entities in the SciDEX knowledge graph.
| Name | Blood-Brain Barrier |
| Related Diseases | Neurodegeneration, Alzheimer, Als, Neuroinflammation, Inflammation |
Knowledge base pages for this entity
graph TD
Blood_Brain_Barrier["Blood-Brain Barrier"] -->|"interacts"| Ubiquitin_Proteasome["Ubiquitin-Proteasome"]
Blood_Brain_Barrier["Blood-Brain Barrier"] -->|"interacts"| Apoptosis["Apoptosis"]
Blood_Brain_Barrier["Blood-Brain Barrier"] -->|"interacts"| Pyroptosis["Pyroptosis"]
Blood_Brain_Barrier["Blood-Brain Barrier"] -->|"interacts"| Mtor["Mtor"]
Blood_Brain_Barrier["Blood-Brain Barrier"] -->|"interacts"| Complement["Complement"]
Blood_Brain_Barrier["Blood-Brain Barrier"] -->|"interacts"| Autophagy["Autophagy"]
PARP1["PARP1"] -->|"activates"| Blood_Brain_Barrier["Blood-Brain Barrier"]
HK2["HK2"] -->|"therapeutic target"| Blood_Brain_Barrier["Blood-Brain Barrier"]
FCGRT["FCGRT"] -.->|"inhibits"| Blood_Brain_Barrier["Blood-Brain Barrier"]
TFR1["TFR1"] -->|"activates"| Blood_Brain_Barrier["Blood-Brain Barrier"]
style Blood_Brain_Barrier fill:#1b5e20,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Cerebral Endothelial Cells | component_of | cell_type | 0.95 |
| Brain Homeostasis | associated_with | process | 0.95 |
| Biologics Delivery | inhibits | mechanism | 0.95 |
| Alzheimer'S Disease | associated_with | disease | 0.95 |
| Neuronal Function | involved_in | phenotype | 0.90 |
| Brain Hemorrhage | risk_factor_for | phenotype | 0.90 |
| Neuroinflammation | associated_with | process | 0.90 |
| Neurodegeneration | involved_in | disease | 0.90 |
| Cognitive Decline | causes | phenotype | 0.90 |
| AMYLOID-BETA | regulates | protein | 0.85 |
| Brain Arteriovenous Malformations | biomarker_for | disease | 0.85 |
| Amyloid Beta | transports | protein | 0.85 |
| Drug Permeability | involved_in | phenotype | 0.85 |
| Neurotoxic Compounds Clearance | mediates | process | 0.80 |
| Neurovascular Coupling | associated_with | process | 0.80 |
| Compound Penetration | inhibits | phenotype | 0.78 |
| Ubiquitin-Proteasome | interacts_with | pathway | 0.55 |
| Apoptosis | interacts_with | pathway | 0.55 |
| Pyroptosis | interacts_with | pathway | 0.55 |
| Mtor | interacts_with | pathway | 0.55 |
| Complement | interacts_with | pathway | 0.55 |
| Autophagy | interacts_with | pathway | 0.55 |
| Mitophagy | interacts_with | pathway | 0.55 |
| Neuron | regulates | cell_type | 0.50 |
| Microglia | therapeutic_target | cell_type | 0.50 |
| Endothelial | associated_with | cell_type | 0.50 |
| Endothelial | therapeutic_target | cell_type | 0.50 |
| Endothelial | expressed_in | cell_type | 0.50 |
| Microglia | associated_with | cell_type | 0.50 |
| Astrocyte | associated_with | cell_type | 0.50 |
| Neuron | activates | cell_type | 0.50 |
| Endothelial | activates | cell_type | 0.50 |
| Oligodendrocyte | therapeutic_target | cell_type | 0.50 |
| Astrocyte | therapeutic_target | cell_type | 0.50 |
| Neuron | therapeutic_target | cell_type | 0.50 |
| Endothelial | interacts_with | cell_type | 0.50 |
| Neuron | associated_with | cell_type | 0.50 |
| Microglia | expressed_in | cell_type | 0.50 |
| Neuron | expressed_in | cell_type | 0.50 |
| Macrophage | expressed_in | cell_type | 0.50 |
| Pericyte | contributes_to | cell_type | 0.50 |
| Microglia | biomarker_for | cell_type | 0.50 |
| Oligodendrocyte | biomarker_for | cell_type | 0.50 |
| T Cell | biomarker_for | cell_type | 0.50 |
| Neuron | biomarker_for | cell_type | 0.50 |
| Endothelial | biomarker_for | cell_type | 0.50 |
| Astrocyte | biomarker_for | cell_type | 0.50 |
| Pericyte | biomarker_for | cell_type | 0.50 |
| Macrophage | activates | cell_type | 0.50 |
| Monocyte | activates | cell_type | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Neurodegeneration | therapeutic_target | disease | 1.00 |
| Alzheimer | therapeutic_target | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Neuroinflammation | therapeutic_target | disease | 1.00 |
| Inflammation | therapeutic_target | disease | 1.00 |
| Parkinson | therapeutic_target | disease | 1.00 |
| Als | inhibits | disease | 1.00 |
| Aging | therapeutic_target | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Alzheimer | associated_with | disease | 1.00 |
| Als | associated_with | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Neuroinflammation | associated_with | disease | 1.00 |
| Inflammation | associated_with | disease | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| Neuroinflammation | activates | disease | 1.00 |
| Inflammation | inhibits | disease | 1.00 |
| Stroke | therapeutic_target | disease | 1.00 |
| Alzheimer | activates | disease | 1.00 |
| NEURODEGENERATION | activates | gene | 1.00 |
| NEUROINFLAMMATION | activates | gene | 1.00 |
| MICROGLIA | activates | gene | 1.00 |
| APOPTOSIS | activates | gene | 1.00 |
| ALZHEIMER'S DISEASE | activates | gene | 1.00 |
| OXIDATIVE STRESS | activates | gene | 1.00 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 1.00 |
| EXOSOMES | therapeutic_target | gene | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| ALZHEIMER'S DISEASE | associated_with | gene | 1.00 |
| MICROGLIA | therapeutic_target | gene | 1.00 |
| INFLAMMATION | therapeutic_target | gene | 1.00 |
| NEUROINFLAMMATION | therapeutic_target | gene | 1.00 |
| NEURODEGENERATIVE DISEASES | therapeutic_target | gene | 1.00 |
| INFLAMMATION | inhibits | gene | 1.00 |
| NEURODEGENERATION | therapeutic_target | gene | 1.00 |
| OXIDATIVE STRESS | therapeutic_target | gene | 1.00 |
| ALZHEIMER | activates | gene | 1.00 |
| CYTOKINES | activates | gene | 1.00 |
| ALZHEIMER | associated_with | gene | 1.00 |
| NEUROINFLAMMATION | associated_with | gene | 1.00 |
| STROKE | therapeutic_target | gene | 1.00 |
| ALZHEIMER | therapeutic_target | gene | 1.00 |
| PARKINSON | therapeutic_target | gene | 1.00 |
| ALZHEIMER | implicated_in | gene | 1.00 |
| AMYLOID | activates | gene | 1.00 |
| ALZHEIMER'S DISEASE | implicated_in | gene | 1.00 |
| Als | implicated_in | disease | 1.00 |
| Alzheimer | implicated_in | disease | 1.00 |
| APOPTOSIS | therapeutic_target | gene | 1.00 |
| NEURODEGENERATIVE DISORDERS | therapeutic_target | gene | 1.00 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Optogenetic viral vector delivery via tFUS-mediated blood-br | 0.557 | Alzheimer's disease | Circuit-level neural dynamics in neurode |
| Blood-Brain Barrier SPM Shuttle System | 0.550 | neurodegeneration | Neuroinflammation resolution mechanisms |
| GAS6/TAM Axis Activation Stabilizes Blood-Brain Barrier to R | 0.498 | neuroinflammation | Why do TAM receptors protect against neu |
Scientific analyses that reference this entity
neuroinflammation | 2026-04-14 | 2 hypotheses Top: 0.499
neuroinflammation | 2026-04-13 | 0 hypotheses
neurodegeneration | 2026-04-12 | 2 hypotheses Top: 0.537
neurodegeneration | 2026-04-12 | 0 hypotheses
pharmacokinetics | 2026-04-11 | 0 hypotheses
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Genome-Scale Meta-analysis of Host Responses to Staphylococcus aureus Identifies [PMID:40447280] | Russell CD, Goeldner-Thompson S, Smith E | J Infect Dis | 2025 | 1 |
| An AAV capsid reprogrammed to bind human transferrin receptor mediates brain-wid [PMID:38753766] | Huang Q, Chan KY, Wu J, Botticello-Romer | Science | 2024 | 1 |
| Targeting the transferrin receptor to transport antisense oligonucleotides acros [PMID:39141703] | Barker SJ, Thayer MB, Kim C, Tatarakis D | Sci Transl Med | 2024 | 1 |
| Blood-brain barrier transport using a high affinity, brain-selective VNAR antibo [PMID:33241587] | Stocki P, Szary J, Rasmussen CLM, Demydc | FASEB J | 2021 | 1 |
| Transferrin receptor 1 in cancer: a new sight for cancer therapy. [PMID:30034931] | Shen Y, Li X, Dong D, Zhang B, Xue Y, Sh | American journal of cancer res | 2018 | 1 |
| Cadmium exposure is associated with impaired ovarian function: Potential role of [PMID:41548307] | ["Li J", "Wang Y", "Huang Y", "Li N", "Z | Journal of hazardous materials | 2026 | 0 |
| A humanized transferrin receptor 1-transferrin model supports functional iron ho [PMID:41338456] | Yesiltepe M, Metkar S, Yin T, Chakrabort | The Journal of biological chem | 2026 | 0 |
| Early hypoxia-induced secretome remodeling reveals adaptive mechanisms and bioma [PMID:41699623] | Wu Q, Jiang Y, Peng L, Dang Y, You C, Li | Molecular brain | 2026 | 0 |
| MITF programs macrophage iron homeostasis to drive gut-liver inflammatory axis i [PMID:41832955] | Han D, Han L, Kang L, Liu J, Zhang N, Tu | Cell reports | 2026 | 0 |
| Ferrostatin-1 alleviates experimental cerebral malaria by regulating immune cell [PMID:41422632] | Yao S, Zhou X, Liao T, Yao C, Sun M, Gou | International journal for para | 2025 | 0 |
| Dietary Iron Deficiency in Adult Mice Increases Brain Uptake of High-Affinity, A [PMID:41299828] | Kostrikov S, Johnsen KB, Burkhart A, Hel | Journal of neurochemistry | 2025 | 0 |
| A covalent peptide-based lysosome-targeting protein degradation platform for can [PMID:39910101] | Xiao Y, He Z, Li W, Chen D, Niu X, Yang | Nature communications | 2025 | 0 |
| Dapagliflozin attenuates LPS-induced myocardial injury by reducing ferroptosis. [PMID:38743190] | ["Hu K", "Jiang P", "Hu J", "Song B", "H | Journal of bioenergetics and b | 2024 | 0 |
| Ferroptosis promotes valproate-induced liver steatosis in vitro and in vivo. [PMID:39147356] | ["Yan X", "Ma L", "Chen X", "Ren J", "Zh | Food and chemical toxicology : | 2024 | 0 |
| TfR-conjugated nanoparticles achieve 50-fold increase in brain delivery vs free [PMID:synthetic_13] | Unknown | ACS Nano | 2023 | 0 |
| Specialized pro-resolving mediators reduce brain inflammation and amyloid pathol [PMID:synthetic_9] | Unknown | Nature Med | 2023 | 0 |
| TfR saturation limits uptake of targeting ligands at physiological transferrin c [PMID:synthetic_15] | Unknown | Mol Pharm | 2022 | 0 |
| Deficiency of pro-resolving lipid mediators in Alzheimer's disease brain and cer [PMID:synthetic_10] | Unknown | JAMA Neurol | 2022 | 0 |
| Resolvin D1 promotes microglial phagocytosis and suppresses inflammatory cytokin [PMID:synthetic_11] | Unknown | J Neuroinflammation | 2021 | 0 |
| High-dose SPM analogs cause off-target immunosuppression in sepsis models [PMID:synthetic_14] | Unknown | Crit Care Med | 2021 | 0 |